Gastrointestinal Hormones in Cancer
Author:
Publisher
Elsevier
Reference61 articles.
1. A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer;Abbruzzese;Pancreas,1992
2. Advances and current concepts in the medical management of gastroenteropancreatic neuroendocrine neoplasms;Alexandraki;BioMed Research International,2017
3. Beta-glucans and cancer: The influence of inflammation and gut peptide;Baldassano;European Journal of Medicinal Chemistry,2017
4. Potential clinical indications for a CCK2 receptor antagonist;Boyce;Current Opinion in Pharmacology,2016
5. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis;Boyce;British Journal of Clinical Pharmacology,2017
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Urinary VPAC1: A potential biomarker in prostate cancer;AIMS Allergy and Immunology;2022
2. Bombesin receptors as potential targets for anticancer drug delivery and imaging;The International Journal of Biochemistry & Cell Biology;2019-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3